|
| |
COMT
Gene Information from Publications |
| Publication Link |
Summary of findings |
| 17962094 |
COMT val158met polymorphism is associated with life time fracture prevalence in elderly Swedish men |
| 17525974 |
catechol-O-methyltransferase (Val158Met) polymorphism moderates affective and psychotic responses to stress in patients with psychosis, providing evidence for gene-environment interaction mechanisms in the formation of psychotic symptoms. |
| 18194840 |
Observational study of gene-disease association. (HuGE Navigator) |
| 18197080 |
Observational study of gene-disease association. (HuGE Navigator) |
| 18198266 |
Observational study of gene-disease association. (HuGE Navigator) |
| 18199630 |
Observational study of gene-disease association. (HuGE Navigator) |
| 18201871 |
Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator) |
| 18213617 |
Observational study of gene-disease association. (HuGE Navigator) |
| 18214863 |
Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator) |
| 18214865 |
Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator) | →View more information from publications. |
Recent Publications on COMT: |  |
Association analysis of COMT polymorphisms with schizophrenia and smooth pursuit eye movement abnormality.
Schizophrenia is a multifactorial disorder characterized by the... | 3rd November, 2009
| Department of Genetic Epidemiology, SNP Genetics, Seoul, Republic of
| J Hum Genet. 2009 Oct 30.
DOI Direct Link |
Entacapone, a catechol-O-methyltransferase inhibitor, improves the motor activity and dopamine content of basal ganglia in a rat model of Parkinson's disease induced by Japanese encephalitis virus.
Levodopa is the main medication used for the treatment of Parkinson's... | 3rd November, 2009
| Department of Molecular Biosciences, School of Pharmaceutical Sciences,
| Brain Res. 2009 Oct 28.
DOI Direct Link |
Possible Risk Modification by Polymorphisms of Estrogen Metabolizing Genes in Familial Breast Cancer Susceptibility in an Indian Population.
ABSTRACT This case control study investigated whether polymorphisms of... | 30th October, 2009
| Regional Cancer Centre, Division of Cancer Research, Medical College Post,
| Cancer Invest. 2009 Oct 28.
|
A Candidate Gene Analysis of Methylphenidate Response in Attention-Deficit/Hyperactivity Disorder.
OBJECTIVE:: This study examines the potential role of candidate genes in... | 28th October, 2009
| Drs. McGough, McCracken, and Suddath are with the Semel Institute for
| J Am Acad Child Adolesc Psychiatry. 2009 Oct 23.
DOI Direct Link |
The association of catechol-O-methyltransferase genotype with the phenotype of women with eating disorders.
Objective: The modern brain imaging studies in patients with eating... | 27th October, 2009
| Department of Psychiatry, Pomeranian Medical University, Broniewskiego 26;
| Brain Res. 2009 Oct 21.
DOI Direct Link |
→View more research publications. |
Press Releases on COMT:
|
 |
| Reportlinker Adds Alzheimer's and Parkinson's Diseases - A Global Update of Market Trends & Opportunities |
18th November, 2009 |
Reportlinker |
NEW YORK, Nov. 18 /PRNewswire/ --
Reportlinker.com announces that a new market research report is available in its catalogue.
Merck Serono Initiates SETTLE, the Second Phase III Clinical Trial of Safinamide in Advanced Parkinson's Disease |
7th May, 2009 |
|
GENEVA, Switzerland, May 7 /PRNewswire/ -- Merck Serono, a division of Merck KGaA, Darmstadt, Germany,
and its partner Newron Pharmaceuticals SpA (SWX: NWRN) announced today the
initiation of the
|
| Merck Serono's Safinamide Significantly Improved Motor Function in Patients With Advanced Parkinson's Disease in a Phase III Pivotal Trial |
3rd February, 2009 |
|
GENEVA, Switzerland, February 3 /PRNewswire/ -- Merck Serono, a division of Merck KGaA, Darmstadt, Germany, and its
partner Newron Pharmaceuticals SpA (SWX: NWRN) announced today that the first
|
| CeNeS and Tripos Announce Advances in COMT inhibitor discovery programme |
1st December, 2004 |
Cenes |
CeNeS and Tripos Announce
Advances in COMT inhibitor discovery programme
|
| Improving levodopa-based complications to advance Parkinson's Disease
|
1st January, 1970 |
Dailyupdates |
Improving
levodopa
|
COMT results (if any) from reagent suppliers | 
|
Search Bioportfolio and other Life Science Sites for COMT,
or search for COMT on BioPortfolio's antibody search engine.
This page has been viewed 610 times
Recent Search Terms used to find this page: comt cognition | mouse catechol-O-methyltransferase (Comt | catechol-o-methyltransferase | COMT | COMT | treatment resistant TB and comt inhibition | COMT inhibitors patent | SPA assay catechol-O-methyltransferase | emzynes comt | .
Resources from the NCBI used on this page, NCBI's standard disclaimer applies.
|
